Pseudothrombocytopenia as a pitfall in the treatment of essential thrombocythemia.
Braester
Andre
A
D000328:Adult; D000368:Aged; D000373:Agglutinins / Q000276:immunology; D000925:Anticoagulants / Q000494:pharmacology*; D016477:Artifacts; D001323:Autoantibodies / Q000276:immunology; D019343:Citric Acid / Q000494:pharmacology; D003937:Diagnosis, Differential; D004492:Edetic Acid / Q000494:pharmacology*; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000276:immunology; D010976:Platelet Count; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000276:immunology; D012969:Sodium Fluoride / Q000494:pharmacology; D013920:Thrombocythemia, Essential / Q000097:blood* / Q000188:drug therapy; D013921:Thrombocytopenia / Q000175:diagnosis*
D000373:Agglutinins; D000925:Anticoagulants; D001323:Autoantibodies; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D019343:Citric Acid; D012969:Sodium Fluoride; D006493:Heparin; D004492:Edetic Acid; D006918:Hydroxyurea